查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2027554

醫藥包裝市場機會、成長要素、產業趨勢分析及2026-2035年預測。

Pharmaceutical Packaging Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球藥品包裝市場價值 1,726 億美元，預計到 2035 年將達到 7,446 億美元，年複合成長率為 15.9%。

醫藥包裝市場-IMG1

市場擴張的驅動力在於不斷成長的藥品需求，而這又源自於人口老化和慢性病盛行率的上升。這種轉變催生了對可靠、高性能包裝解決方案日益成長的需求，這些解決方案能夠維持藥品品質並確保整個供應鏈的安全。製造商正在開發採用各種材料的多樣化包裝形式，以提高產品穩定性、延長保存期限並維持治療效果。尤其值得關注的是，為了應對不斷成長的藥品產量，耐用且化學性質穩定的容器的開發正受到越來越多的關注。輕質高強度材料的創新在提升包裝性能的同時，也滿足了法規要求。同時，對藥品安全和品質保證的嚴格合規要求正在推動先進包裝技術的應用。製劑研發流程的日益複雜化進一步強化了對高精度、無菌和防護性包裝系統的需求。

市場範圍
開始年份 2025
預測期 2026-2035
上市時的市場規模 1726億美元
預測金額 7446億美元
複合年成長率 15.9%

到2025年，初級包裝市場佔有率將達到70.4%，這反映了其在產品直接封裝和保護方面發揮的關鍵作用。該領域的成長主要得益於對高無菌性、化學穩定性和污染控制要求的藥品製劑的需求不斷成長。專為與藥品直接接觸而設計的包裝解決方案對於維持產品完整性、確保安全性以及滿足嚴格的合規標準至關重要。阻隔技術的不斷進步以及消費者對即用型包裝形式的偏好，進一步鞏固了該領域的主導地位。對高效、安全且擴充性的包裝解決方案的需求，持續推動該領域的創新。

憑藉其可靠性、耐用性和強大的保護性能，硬質包裝預計到2025年將佔據56.5%的市場佔有率。該細分市場受益於其在藥品包裝領域的廣泛應用，這些藥品需要結構完整性和抵禦外部因素的能力。硬包裝解決方案透過提供更佳的保護、延長保存期限和防篡改功能，對於維護產品安全和符合法規要求至關重要。預填充灌封和即用型包裝的持續普及進一步推動了該細分市場的需求，因為這些解決方案提高了整個藥品生產和分銷流程的效率。

預計到2025年，北美醫藥包裝市佔率將達到35.3%，主要得益於市場對高品質、合規包裝解決方案的強勁需求。該地區正日益廣泛地採用旨在增強藥物保護、維持無菌狀態並確保患者安全的先進材料和技術。特別是複雜製劑產量的不斷成長，推動了對高性能包裝系統的需求。法律規範和永續性措施也促進了創新型環保包裝材料的使用。包裝技術的創新和對基礎設施的持續投資，共同支撐著該地區市場的穩定擴張。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章業界考察

  • 生態系分析
    • 供應商情況
    • 利潤率
    • 成本結構
    • 每個階段增加的價值
    • 影響價值鏈的因素
    • 中斷
  • 影響產業的因素
    • 促進因素
      • 嚴格的藥品安全法規
      • 老化與慢性疾病
      • 全球對藥品的需求不斷成長
      • 包裝領域的技術進步
      • 偏好即用型包裝
    • 產業潛在風險與挑戰
      • 材料易碎性和搬運風險
      • 高昂的生產成本
    • 市場機遇
      • 採用即用型包裝
      • 永續且環保的包裝解決方案
  • 成長潛力分析
  • 監理情勢
  • 波特五力分析
  • PESTEL 分析
  • 科技與創新趨勢
    • 當前技術趨勢
    • 新興技術
  • 價格趨勢
    • 按地區
    • 依產品
  • 定價策略
  • 新興經營模式
  • 合規要求
  • 專利和智慧財產權分析

第4章 競爭情勢

  • 介紹
  • 企業市佔率分析
    • 按地區
    • 市場集中度分析
  • 主要公司的競爭標竿分析
    • 財務績效比較
      • 銷售量
      • 利潤率
      • 研究與發展（R&D）
    • 產品系列比較
      • 產品線寬度
      • 科技
      • 創新
    • 區域擴張比較
      • 全球擴張分析
      • 服務網路覆蓋
      • 按地區分類的市場滲透率
    • 競爭定位矩陣
      • 領導者
      • 挑戰者
      • 追蹤者
      • 小眾玩家
  • 主要進展
    • 併購
    • 夥伴關係和聯盟
    • 技術進步
    • 業務拓展與投資策略
    • 數位轉型計劃
  • 新興競爭對手和新創競爭對手的發展趨勢

第5章 市場估價與預測：依包裝類型分類，2022-2035年

  • 初級包裝
    • 吸塑包裝
    • 瓶子和容器
    • 管瓶和安瓿
    • 預填充式注射器和藥筒
    • 小袋小袋
    • 其他
  • 二級包裝
    • 紙箱
    • 標籤和傳單
    • 托盤
  • 三級包裝
    • 調色盤
    • 瓦楞紙箱
    • 拉伸膜和收縮膜

第6章 市場估價與預測：依包裝類型分類，2022-2035年

  • 硬包裝
  • 半剛性包裝
  • 軟包裝

第7章 市場估計與預測：依材料類型分類，2022-2035年

  • 塑膠
    • HDPE
    • PET
    • PP
    • PE
    • 其他
  • 玻璃
  • 鋁
  • 紙張和紙板
  • 其他

第8章 市場估計與預測：依功能分類，2022-2035年

  • 傳統包裝
  • 無菌包裝
  • 兒童安全防篡改包裝
  • 啟用序列化的包
  • 溫控包裝（低溫運輸）

第9章 市場估計與預測：依劑型分類，2022-2035年

  • 固態劑型
  • 液體和注射劑
  • 生物製藥和生物相似藥
  • 經皮/局部用藥
  • 眼科
  • 呼吸系統和吸入藥物
  • 其他

第10章 市場估價與預測：依最終用戶分類，2022-2035年

  • 製藥公司
  • 契約製造
  • 醫院和醫療設施
  • 零售藥房

第11章 市場估價與預測：按地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 俄羅斯
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第12章：公司簡介

  • 全球公司：
    • Amcor plc
    • Gerresheimer AG
    • Schott AG
    • West Pharmaceutical Services, Inc.
    • AptarGroup, Inc.
    • Becton, Dickinson and Company（BD）
  • 本地公司：
    • Nipro Corporation
    • SGD Pharma
    • Stevanato Group SpA
    • CCL Industries Inc.
    • Origin Pharma Packaging
    • Alpla Group
  • 本地商家：
    • Datwyler Holding Inc.
    • SCHOTT Kaisha Private Limited
    • Bormioli Pharma
    • Comar LLC
    • Huhtamaki Oyj
簡介目錄
Product Code: 5256

The Global Pharmaceutical Packaging Market was valued at USD 172.6 billion in 2025 and is estimated to grow at a CAGR of 15.9% to reach USD 744.6 billion by 2035.

Pharmaceutical Packaging Market - IMG1

Market expansion is being fueled by the rising demand for pharmaceutical products, supported by a growing aging population and the increasing incidence of long-term health conditions. This shift is accelerating the need for reliable, high-performance packaging solutions that preserve drug quality and ensure safety throughout the supply chain. Manufacturers are advancing packaging formats across multiple material types to enhance product stability, extend shelf life, and maintain therapeutic effectiveness. Increasing attention is being directed toward the development of durable and chemically stable containers, particularly in response to rising pharmaceutical production volumes. Innovation in lightweight and resilient materials is improving packaging performance while aligning with regulatory expectations. At the same time, strict compliance requirements related to drug safety and quality assurance are encouraging the adoption of advanced packaging technologies. The growing pipeline of complex drug formulations is further reinforcing the demand for high-precision, sterile, and protective packaging systems.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$172.6 Billion
Forecast Value$744.6 Billion
CAGR15.9%

The primary packaging segment accounted for 70.4% share in 2025, reflecting its critical role in direct product containment and protection. Growth within this segment is supported by increasing demand for drug formats that require high levels of sterility, chemical stability, and contamination control. Packaging solutions designed for direct contact with pharmaceutical products are essential in maintaining integrity, ensuring safety, and meeting stringent compliance standards. Continued advancements in barrier technologies and the increasing preference for ready-to-use formats are further strengthening the segment's leading position. The need for efficient, safe, and scalable packaging solutions continues to drive innovation in this category.

The rigid packaging segment captured 56.5% share in 2025, driven by its reliability, durability, and strong protective capabilities. This segment benefits from widespread use in packaging pharmaceutical formulations that require structural integrity and resistance to external factors. Rigid packaging solutions provide enhanced protection, extended shelf life, and tamper-evident features, making them essential for maintaining product safety and regulatory compliance. The growing shift toward prefilled and ready-to-use formats is further reinforcing demand within this segment, as these solutions improve efficiency across pharmaceutical manufacturing and distribution processes.

North America Pharmaceutical Packaging Market held a 35.3% share in 2025, supported by strong demand for high-quality and compliant packaging solutions. The region is witnessing increasing adoption of advanced materials and technologies designed to enhance drug protection, maintain sterility, and ensure patient safety. Rising pharmaceutical production, particularly for complex drug formulations, is driving demand for high-performance packaging systems. Regulatory frameworks and sustainability initiatives are also encouraging the use of innovative and environmentally responsible packaging materials. Continued investment in packaging innovation and infrastructure is supporting the region's steady market expansion.

Key companies operating in the Global Pharmaceutical Packaging Market include Alpla Group, Amcor plc, AptarGroup, Inc., Becton, Dickinson and Company (BD), Bormioli Pharma, CCL Industries Inc., Comar LLC, Datwyler Holding Inc., Gerresheimer AG, Huhtamaki Oyj, Nipro Corporation, Origin Pharma Packaging, Schott AG, SCHOTT Kaisha Private Limited, SGD Pharma, Stevanato Group S.p.A., and West Pharmaceutical Services, Inc. Companies in the Pharmaceutical Packaging Market are strengthening their market position through a combination of innovation, strategic expansion, and operational efficiency improvements. Industry participants are investing heavily in advanced packaging technologies that enhance product protection, sterility, and compliance with evolving regulatory standards. Organizations are expanding production capacities and upgrading manufacturing facilities to meet rising global demand. Strategic collaborations and partnerships are being pursued to improve technological capabilities and broaden geographic reach. Companies are also focusing on sustainable packaging solutions, incorporating recyclable materials and environmentally responsible processes to align with regulatory and consumer expectations.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis, 2022 - 2035
  • 2.2 Key market trends
    • 2.2.1 Packaging type trends
    • 2.2.2 Packaging Format trends
    • 2.2.3 Material type trends
    • 2.2.4 Functionality trends
    • 2.2.5 Drug Form trends
    • 2.2.6 End-User trends
    • 2.2.7 Regional trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Profit margin
    • 3.1.3 Cost structure
    • 3.1.4 Value addition at each stage
    • 3.1.5 Factor affecting the value chain
    • 3.1.6 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Stringent regulations on drug safety
      • 3.2.1.2 Aging population and chronic disease
      • 3.2.1.3 Rising global pharmaceutical demand
      • 3.2.1.4 Technological advancement in packaging
      • 3.2.1.5 Preference for ready to use packaging
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Material fragility and handling risks
      • 3.2.2.2 High production costs
    • 3.2.3 Market opportunities
      • 3.2.3.1 Adoption of ready-to-use packaging
      • 3.2.3.2 Sustainable and eco-friendly packaging solutions
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis
  • 3.7 Technology and Innovation landscape
    • 3.7.1 Current technological trends
    • 3.7.2 Emerging technologies
  • 3.8 Price trends
    • 3.8.1 By region
    • 3.8.2 By product
  • 3.9 Pricing Strategies
  • 3.10 Emerging Business Models
  • 3.11 Compliance Requirements
  • 3.12 Patent and IP analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 Latin America
      • 4.2.1.5 Middle East & Africa
    • 4.2.2 Market concentration analysis
  • 4.3 Competitive benchmarking of key players
    • 4.3.1 Financial performance comparison
      • 4.3.1.1 Revenue
      • 4.3.1.2 Profit margin
      • 4.3.1.3 R&D
    • 4.3.2 Product portfolio comparison
      • 4.3.2.1 Product range breadth
      • 4.3.2.2 Technology
      • 4.3.2.3 Innovation
    • 4.3.3 Geographic presence comparison
      • 4.3.3.1 Global footprint analysis
      • 4.3.3.2 Service network coverage
      • 4.3.3.3 Market penetration by region
    • 4.3.4 Competitive positioning matrix
      • 4.3.4.1 Leaders
      • 4.3.4.2 Challengers
      • 4.3.4.3 Followers
      • 4.3.4.4 Niche players
  • 4.4 Key developments
    • 4.4.1 Mergers and acquisitions
    • 4.4.2 Partnerships and collaborations
    • 4.4.3 Technological advancements
    • 4.4.4 Expansion and investment strategies
    • 4.4.5 Digital transformation initiatives
  • 4.5 Emerging/ startup competitors landscape

Chapter 5 Market Estimates and Forecast, By Packaging Type, 2022 - 2035 (USD Million & Kilo Tons)

  • 5.1 Key trends
  • 5.2 Primary packaging
    • 5.2.1 Blister packs
    • 5.2.2 Bottles & containers
    • 5.2.3 Vials & ampoules
    • 5.2.4 Prefilled syringes & cartridges
    • 5.2.5 Pouches & sachets
    • 5.2.6 Others
  • 5.3 Secondary packaging
    • 5.3.1 Cartons & boxes
    • 5.3.2 Labels & leaflets
    • 5.3.3 Trays
  • 5.4 Tertiary packaging
    • 5.4.1 Pallets
    • 5.4.2 Corrugated boxes
    • 5.4.3 Stretch wrap & shrink film

Chapter 6 Market Estimates and Forecast, By Packaging Format, 2022 - 2035 (USD Million & Kilo Tons)

  • 6.1 Key trends
  • 6.2 Rigid packaging
  • 6.3 Semi-rigid packaging
  • 6.4 Flexible packaging

Chapter 7 Market Estimates and Forecast, By Material Type, 2022 - 2035 (USD Million & Kilo Tons)

  • 7.1 Key trends
  • 7.2 Plastics
    • 7.2.1 HDPE
    • 7.2.2 PET
    • 7.2.3 PP
    • 7.2.4 PE
    • 7.2.5 Others
  • 7.3 Glass
  • 7.4 Aluminum
  • 7.5 Paper & paperboard
  • 7.6 Others

Chapter 8 Market Estimates and Forecast, By Functionality, 2022 - 2035 (USD Million & Kilo Tons)

  • 8.1 Key trends
  • 8.2 Conventional packaging
  • 8.3 Sterile packaging
  • 8.4 Child-resistant & tamper-evident packaging
  • 8.5 Serialization-enabled packaging
  • 8.6 Temperature-controlled packaging (Cold-Chain)

Chapter 9 Market Estimates and Forecast, By Drug Form, 2022 - 2035 (USD Million & Kilo Tons)

  • 9.1 Key trends
  • 9.2 Solid dosage
  • 9.3 Liquid/injectable
  • 9.4 Biologics & biosimilars
  • 9.5 Dermal & topical
  • 9.6 Ophthalmic
  • 9.7 Pulmonary/inhalation
  • 9.8 Others

Chapter 10 Market Estimates and Forecast, By End User, 2022 - 2035 (USD Million & Kilo Tons)

  • 10.1 Key trends
  • 10.2 Pharmaceutical manufacturers
  • 10.3 Contract manufacturing
  • 10.4 Hospitals & healthcare facilities
  • 10.5 Retail pharmacies

Chapter 11 Market Estimates and Forecast, By Region, 2022 - 2035 (USD Million & Kilo Tons)

  • 11.1 Key trends
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 France
    • 11.3.4 Spain
    • 11.3.5 Italy
    • 11.3.6 Russia
  • 11.4 Asia Pacific
    • 11.4.1 China
    • 11.4.2 India
    • 11.4.3 Japan
    • 11.4.4 Australia
    • 11.4.5 South Korea
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Argentina
  • 11.6 Middle East and Africa
    • 11.6.1 South Africa
    • 11.6.2 Saudi Arabia
    • 11.6.3 UAE

Chapter 12 Company Profiles

  • 12.1 Global Players:
    • 12.1.1 Amcor plc
    • 12.1.2 Gerresheimer AG
    • 12.1.3 Schott AG
    • 12.1.4 West Pharmaceutical Services, Inc.
    • 12.1.5 AptarGroup, Inc.
    • 12.1.6 Becton, Dickinson and Company (BD)
  • 12.2 Regional Players:
    • 12.2.1 Nipro Corporation
    • 12.2.2 SGD Pharma
    • 12.2.3 Stevanato Group S.p.A.
    • 12.2.4 CCL Industries Inc.
    • 12.2.5 Origin Pharma Packaging
    • 12.2.6 Alpla Group
  • 12.3 Local Players:
    • 12.3.1 Datwyler Holding Inc.
    • 12.3.2 SCHOTT Kaisha Private Limited
    • 12.3.3 Bormioli Pharma
    • 12.3.4 Comar LLC
    • 12.3.5 Huhtamaki Oyj